Cryo Cell International (CCEL) Receivables - Other (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Receivables - Other for 14 consecutive years, with $855142.0 as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other rose 10.32% to $855142.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $855142.0, a 10.32% increase, with the full-year FY2025 number at $855142.0, up 10.32% from a year prior.
- Receivables - Other was $855142.0 for Q4 2025 at Cryo Cell International, up from $831458.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $855142.0 in Q4 2025 to a low of $478370.0 in Q1 2021.
- A 5-year average of $665725.4 and a median of $664884.0 in 2023 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: rose 15.63% in 2022, then rose 9.76% in 2025.
- Cryo Cell International's Receivables - Other stood at $535522.0 in 2021, then grew by 14.96% to $615628.0 in 2022, then grew by 13.01% to $695695.0 in 2023, then rose by 11.42% to $775147.0 in 2024, then rose by 10.32% to $855142.0 in 2025.
- Per Business Quant, the three most recent readings for CCEL's Receivables - Other are $855142.0 (Q4 2025), $831458.0 (Q3 2025), and $814796.0 (Q2 2025).